Quadrant Capital Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,880
| Closed | -$7.13K | – | 1374 |
|
|
2025
Q1 | $7.13K | Buy |
4,880
+4,509
| +1,215% | +$6.58K | ﹤0.01% | 2285 |
|
|
2024
Q4 | $791 | Sell |
371
-389
| -51% | -$829 | ﹤0.01% | 2611 |
|
|
2024
Q3 | $2.13K | Buy |
+760
| New | +$2.13K | ﹤0.01% | 2489 |
|
|
2024
Q2 | – | Sell |
-1,414
| Closed | -$6.32K | – | 2701 |
|
|
2024
Q1 | $6.32K | Hold |
1,414
| – | – | ﹤0.01% | 2253 |
|
|
2023
Q4 | $4.54K | Sell |
1,414
-2,176
| -61% | -$6.99K | ﹤0.01% | 2297 |
|
|
2023
Q3 | $11.4K | Buy |
3,590
+3,104
| +639% | +$9.84K | ﹤0.01% | 1941 |
|
|
2023
Q2 | $2.42K | Sell |
486
-68
| -12% | -$338 | ﹤0.01% | 2375 |
|
|
2023
Q1 | $2.74K | Buy |
554
+518
| +1,439% | +$2.56K | ﹤0.01% | 2368 |
|
|
2022
Q4 | $226 | Sell |
36
-790
| -96% | -$4.96K | ﹤0.01% | 2690 |
|
|
2022
Q3 | $9K | Hold |
826
| – | – | ﹤0.01% | 1913 |
|
|
2022
Q2 | $9K | Sell |
826
-587
| -42% | -$6.4K | ﹤0.01% | 1695 |
|
|
2022
Q1 | $13K | Buy |
1,413
+1,055
| +295% | +$9.71K | ﹤0.01% | 1521 |
|
|
2021
Q4 | $5K | Buy |
358
+272
| +316% | +$3.8K | ﹤0.01% | 1850 |
|
|
2021
Q3 | $2K | Buy |
86
+78
| +975% | +$1.81K | ﹤0.01% | 2099 |
|
|
2021
Q2 | $0 | Buy |
+8
| New | – | ﹤0.01% | 2396 |
|